in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.
.
.
on critical illness, 4.6 per cent of claims were declined due to the definition not being met and 2.3 per cent were due to misrepresentation.
.
sponsored by an innovative medicines canada company
.
.
one downside to existing drugs that prevent migraine is they can cause unpleasant side effects like
.
.